Results 91 to 100 of about 2,238 (188)

Successful Management of Hemolytic Anemia Due to Rh-immunization, Diagnosed Antenatally

open access: yesCaucasian Medical Journal
Hemolytic disease of the fetus and newborn (HDFN) remains a significant concern in maternal-fetal medicine, despite advancements in prevention and management.
Sevinch Mahmudova   +4 more
doaj   +1 more source

Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn [PDF]

open access: yes
ObjectiveNipocalimab is a neonatal fragment crystallizable (Fc) receptor (FcRn)—blocking monoclonal antibody that inhibits placental immunoglobulin G (IgG) transfer and lowers circulating maternal IgG levels.
Lam, E.   +43 more
core   +1 more source

A rare case of hemolytic disease-associated thrombocytopenia mimicking alloimmune thrombocytopenia: Salvaging a precious baby

open access: yesAsian Journal of Transfusion Science
Thrombocytopenia associated with hemolytic disease of fetus and newborn (HDFN) is usually mild-to-moderate severity. Neonatal alloimmune thrombocytopenia (NAIT) is one of the leading causes of severe thrombocytopenia in neonates.
Pandeep Kaur   +5 more
doaj   +1 more source

Unraveling complexity: A case report on ABO hemolytic disease of the fetus newborn in a preterm neonate and delayed hemolytic transfusion reaction in the beta thalassemic mother due to alloanti kidd a antibody

open access: yesAsian Journal of Transfusion Science
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana   +5 more
doaj   +1 more source

“Block D” Phenomenon in Hemolytic Disease of Fetus and Newborn: The Immunohematological Implications

open access: yesGlobal Journal of Transfusion Medicine
Background and Objectives: “Block D” in hemolytic disease of the fetus and newborn (HDFN) is quite rare and should be evaluated meticulously. We analyzed “Block D” phenomenon in neonates with HDFN due to rhesus (Rh) incompatibilities.
Sourav Mukherjee   +2 more
doaj   +1 more source

Haemolytic Disease of Foetus and Newborn and Haemolytic Transfusion Reaction Due to Kidd antibody in Hospital Umum Sarawak, Malaysia

open access: yes, 2017
Haemolytic Disease of Foetus and Newborn (HDFN) and Haemolytic Transfusion Reaction (HTR) may occur due to antibodies against Kidd antigen. In Malaysia, the prevalence of RBC alloimmunization due to Kidd antibody for cases of HDFN and HTR have been ...
Anis Amalina
core  

Prevalence of IgG subclasses (IgG1/IgG3) in Antenatal Alloimmunized Women: Experience in a Tertiary Hospital in South India [PDF]

open access: yes, 2015
OBJECTIVE: To study the prevalence of IgG subclasses (IgG1 and IgG3) in antenatal alloimmunized women in South India and to correlate it with occurrence and severity of Hemolytic Disease of Fetus and Newborns (HDFN). METHODOLOGY: 85 antenatal women with
Jui, Choudhuri
core  

Fetal treatment and long-term neonatal outcomes in severe maternal red cell alloimmunization – a single-centre experience

open access: yesCase Reports in Perinatal Medicine
Haemolytic disease of the fetus and newborn (HDFN) occurs due to maternal IgG alloantibodies that actively cross the placenta and bind to paternally derived fetal antigens on the erythrocytes.
Mesarič Vita Andreja   +7 more
doaj   +1 more source

Five Pathogenetic Classifications for Alloimmune Hemolytic Disease of the Fetus And Newborn

open access: yes
Maternal alloantibody-induced hemolytic disease of the fetus and newborn (HDFN) remains a significant concern worldwide. Alloimmune HDFN can be pathogenetically named by the specific alloantibodies involved.
Ohto, Hitoshi   +6 more
core   +1 more source

Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn

open access: yes, 2017
Common causes of fetal anemia and hydrops include parvovirus B19 infection during the first 2 trimesters of pregnancy, as well as maternal alloimmunization to RhD with subsequent hemolytic disease of the fetus and newborn (HDFN) in an RhD positive fetus.
Edwina J Popek, Whitney A McCarthy
core   +1 more source

Home - About - Disclaimer - Privacy